Ameritas Investment Partners, Inc. Akebia Therapeutics, Inc. Transaction History

Ameritas Investment Partners, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.32 - $0.67 $3,680 - $7,705	-11,500 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$6.67 - $13.58 $9,017 - $18,360	1,352 Added 13.32%	11,500 $156,000
Q2 2019 Aug 14, 2019	BUY	$4.1 - $8.05 $14,267 - $28,014	3,480 Added 52.19%	10,148 $49,000
Q4 2018 Feb 12, 2019	BUY	$5.39 - $9.15 $15,388 - $26,123	2,855 Added 74.88%	6,668 $37,000
Q4 2017 Feb 14, 2018	BUY	$14.24 - $19.59 $14,425 - $19,844	1,013 Added 36.18%	3,813 $57,000

Q2 2017 Aug 15, 2017	BUY	N/A	2,800	2,800 $40,000

127

56.7M

937K

743K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $188M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.